T Cell-depleted Hla-haploidentical Stem Cell Transplantation in Thalassemia Young Patients

Overview

Journal Pediatr Rep

Publisher MDPI

Specialty Pediatrics

Date 2011 Nov 5

PMID 22053275

Citations 19

Authors

Pietro Sodani

Antonella Isgro

Javid Gaziev

Katia Paciaroni

Marco Marziali

Maria Domenica Simone

Andrea Roveda

Gioa De Angelis

Cristiano Gallucci

Fabio Torelli

Giancarlo Isacchi

Francesco Zinno

Fabiola Landi

Gaspare Adorno

Alessandro Lanti

Manuela Testi

Marco Andreani

Guido Lucarelli

Affiliations

Soon will be listed here.

Citing Articles

Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review.

Mulas O, Mola B, Caocci G, La Nasa G J Clin Med. 2022; 11(4).

PMID: 35207178 PMC: 8876955. DOI: 10.3390/jcm11040907.

Hematopoietic stem cell transplantation for people with β-thalassaemia.

Sharma A, Jagannath V, Puri L Cochrane Database Syst Rev. 2021; 4:CD008708.

PMID: 33880750 PMC: 8078520. DOI: 10.1002/14651858.CD008708.pub5.

No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease.

Lertthammakiat S, Sitthirat P, Anurathapan U, Songdej D, Pakakasama S, Chuansumrit A Thromb J. 2020; 18(1):21.

PMID: 33327955 PMC: 7739460. DOI: 10.1186/s12959-020-00232-z.

[Advances in haploidentical hematopoietic stem cell transplantation for non-malignant hematological diseases].

Fu H, Huang X Zhonghua Xue Ye Xue Za Zhi. 2018; 39(8):691-696.

PMID: 30180476 PMC: 7342844. DOI: 10.3760/cma.j.issn.0253-2727.2018.08.018.

Transplantation in patients with iron overload: is there a place for magnetic resonance imaging? : Transplantation in iron overload.

Mavrogeni S, Kolovou G, Bigalke B, Rigopoulos A, Noutsias M, Adamopoulos S Heart Fail Rev. 2018; 23(2):173-180.

PMID: 29359261 DOI: 10.1007/s10741-018-9670-7.

References

Lucarelli G, Galimberti M, Giardini C, Polchi P, Angelucci E, Baronciani D . Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci. 1998; 850:270-5. DOI: 10.1111/j.1749-6632.1998.tb10483.x. View

Isgro A, Marziali M, Sodani P, Gaziev J, Erer B, Polchi P . Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia. Biol Blood Marrow Transplant. 2010; 16(11):1557-66. DOI: 10.1016/j.bbmt.2010.05.003. View

Shlomchik W, Couzens M, Tang C, McNiff J, Robert M, Liu J . Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999; 285(5426):412-5. DOI: 10.1126/science.285.5426.412. View

Ball L, Bernardo M, Roelofs H, Lankester A, Cometa A, Egeler R . Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007; 110(7):2764-7. DOI: 10.1182/blood-2007-04-087056. View

Lucarelli G, Clift R, Galimberti M, Polchi P, Angelucci E, Baronciani D . Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood. 1996; 87(5):2082-8. View

La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G . Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci. 2005; 1054:186-95. DOI: 10.1196/annals.1345.023. View

Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S . Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005; 23(15):3447-54. DOI: 10.1200/JCO.2005.09.117. View

Polchi P, Lucarelli G, Galimberti M, Giardini C, Baronciani D, Angelucci E . Haploidentical bone marrow transplantation from mother to child with advanced leukemia. Bone Marrow Transplant. 1995; 16(4):529-35. View

Sodani P, Isgro A, Gaziev J, Polchi P, Paciaroni K, Marziali M . Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. Blood. 2009; 115(6):1296-302. DOI: 10.1182/blood-2009-05-218982. View

10.

Lazarus H, Koc O, Devine S, Curtin P, Maziarz R, Holland H . Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005; 11(5):389-98. DOI: 10.1016/j.bbmt.2005.02.001. View

11.

Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C . Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow.... Blood. 1994; 84(11):3948-55. View

12.

Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C . Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993; 329(12):840-4. DOI: 10.1056/NEJM199309163291204. View

13.

Horwitz E, Prockop D, Fitzpatrick L, Koo W, Gordon P, Neel M . Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999; 5(3):309-13. DOI: 10.1038/6529. View

14.

Sodani P, Gaziev D, Polchi P, Erer B, Giardini C, Angelucci E . New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood. 2004; 104(4):1201-3. DOI: 10.1182/blood-2003-08-2800. View

15.

Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A . The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol. 2003; 33(6):1657-66. DOI: 10.1002/eji.200323986. View